TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: missed opportunities for vaccine initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: life-style behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary 6‐sulfatoxymelatonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in QTcF (ΔΔQTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Abundance of otopathogens in nasopharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean abundance of S. salivarius in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients who developed one or more complications
Endpoint domain: Adverse events/effects
Primary endpoint: Vertical Jump performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mean VAS pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Complications (RCOR)
Endpoint domain: Adverse events/effects
Primary endpoint: Uremic toxins plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: LPS plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decreased mean days of ventilator support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased ICP after craniotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response time in the Sternberg Memory Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain reduction at first reassessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of rescue therapy use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: neck pain-related work productivity loss
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Symptomatic anastomotic leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average cost of care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in biomarkers of exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: F1 score for nonmedical use
Endpoint domain: Adverse events/effects
Primary endpoint: F1 score for side effects
Endpoint domain: Adverse events/effects
Primary endpoint: LLVD (Lung Lymphatic Volume Distribution)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in surgical management
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: shift towards death or dependence (mRS > 3)
Endpoint domain: Mortality/survival
Primary endpoint: Risk of Gestational Diabetes Mellitus (GDM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: amygdala reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: stimulated production of TNF‐α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: stimulated production of IL‐6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in cellulite appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in skin laxity appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient question-asking about glaucoma
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient question-asking about glaucoma medications
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Provider education about glaucoma
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: 30-day satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 90-day satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CoPRMS value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CoPRange value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuropathy progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cancer-specific disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: mean past-week drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean past-week standard drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean Craving Experience Questionnaire frequency scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum oligosaccharides levels (LeA and BGH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of minimal MG manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inter-proximal marginal bone-level changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gross manual dexterity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: month 3-18 prednisone AUDTC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: initial times of prednisone reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median daily prednisone dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: instrumentation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Identification of VTE risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 18-month language scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen saturation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: serum gentamicin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI synovitis grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Average cost per person newly diagnosed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost per person initiated on ART
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 10 min Apgar score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of NT-proBNP, HMGB1, ACTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Developmental quotient scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: improvement of painful catching/locking of the jaw
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of eating ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of jaw function limitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall utility value
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Negative prototypes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GMT antibody responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: vertical dimension of the mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: grade ≥ 3 treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: DEQ5 scores at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Investigator's Global Assessment 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any Intimate Partner Violence (IPV)
Endpoint domain: Adverse events/effects
Primary endpoint: days of opioid abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality risk associated with AVF use
Endpoint domain: Mortality/survival
Primary endpoint: catheter-dependence duration after AVF creation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AVF maturation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of DRP resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medicine and Disease Information domain score of the PROMPT‐QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EuroQoL‐Visual Analog Scale score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total corneal fluorescein staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eye dryness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Water Loss (%BWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum leiomyoma volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete amenorrhea rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri-implant soft tissue changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rescue analgesic intake of paracetamol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: self-reported school functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: GNRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: FMA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: MBI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: cutaneous sensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative SEH incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Time to negative rRT‐PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area of PUSH wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of analgesic consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean plaque area at fitting surfaces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hearing loss rates
Endpoint domain: Adverse events/effects
Primary endpoint: Dysphagia rates
Endpoint domain: Adverse events/effects
Primary endpoint: Neck fibrosis rates
Endpoint domain: Adverse events/effects
Primary endpoint: Scores of MCQs test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive feedback
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Strength changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptions of effort, motivation, enjoyment, and supervision quality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oral impact on daily performances (OIDP > 0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incidence of pre‐term delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: incidence of early neonatal death
Endpoint domain: Mortality/survival
Primary endpoint: Knowledge transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in performing cystoscopy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Course interest
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: quality of standardized medical care (SMC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: whole-network prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: network parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MCV1 timely coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strength of passive resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relationship with body and food
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: emotional and psychological issues
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lateral shift in contact forces across the lateral patellar facet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parental psychological distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daytime asthma symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: nighttime asthma symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: use of bronchodilators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Urinary excretion of 2/3-MCPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer angina episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: less pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in SAQ score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean improvement in treatment efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean fasting plasma glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: working memory gains after therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency of hyperglycemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Energy/Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: ORHQoL improvements
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of clean root canal walls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of clean dentinal tubules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calcium hydroxide removal from the apical root third
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nonrelapse mortality (NRM)
Endpoint domain: Mortality/survival
Primary endpoint: quality-of-life improvements
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean DALYs accumulated per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Effectiveness of oxygen uptake ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of carbon dioxide exhaust ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen uptake per unit work rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute reduction in eGFR >10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Hospital budget savings
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Infarct progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of diabetic macular edema treatment
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of epiretinal membrane
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-reported symptoms rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasmin-antiplasmin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: A1c level indicative of diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduced eveningness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: incidence of suicide-related events
Endpoint domain: Mortality/survival
Primary endpoint: Within-period intra-cluster correlation coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cluster autocorrelation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SSE (Systemic Embolic Events)
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in psychiatric inpatient days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Mental health outcomes
Primary endpoint: Improvement in life-space
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Falls efficacy in performing daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Caloric beverage intake (% energy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GM volume loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adverse events associated with adrenal insufficiency
Endpoint domain: Adverse events/effects
Primary endpoint: freedom from ATas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: self-reported ability to manage stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived ability to recognize stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Agreement in volumetric assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time expenditure for tumor segmentation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Suicidal ideation response to placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coherence ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood sodium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: functional capacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glide path enlargement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune response of mOPV2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: perioperative consumption of RBC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: perioperative consumption of fresh frozen plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Correlation Coefficient (CC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalized Root-Mean-Square Error (NRMSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gonadotropins (FSH and LH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: total cortisol and cortisol binding globulin (CBG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of medications for IOP control
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum 1,25(OH)2D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laboratory-confirmed viral respiratory infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinical respiratory infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: treatment success at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: primary safety end-point events within 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: total number of motile spermatozoa ejaculated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: cTnT elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HRV indices alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of Ventilation (LOV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scale of fragility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocyte levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Correct diagnosis of TPTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort with POCUS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ischemic stroke/systemic thromboembolism, death, and rehospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Safety and tolerability of TPN171H
Endpoint domain: Adverse events/effects